In the spreadsheet above I have tracked the earnings estimates for the Biotech ETF (IBB) top 30 holdings.
The column under the date 5/26/2022 has a letter that represents the movement in 2022 earnings estimates since the most recent print (3/26/2022). “U” means 2022 estimates are UP in the last 60 days. “D” means 2022 estimates are DOWN in the last 60 days. “S” means 2022 estimates have remained the SAME in the last 60 days. The column entitled “1yr Target Est” is the Wall Street consensus 12 month price target for each stock.
What this table is telling us is that estimates have moved UP in the past 60 days. More estimates went UP for 2022 in the past 60 days than came down. UP:DOWN 18:10 ratio.
The cumulative 2022 earnings power of these 30 stocks were revised UP by 0.66% in the past 60 days and 2023 earnings were revised down by -4.26%.
